Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...

Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...

- Nellcor™ Pulse Oximetry Technology Demonstrated Statistically Significant Difference in Time to Deliver a Stable Oxygen Saturation Value and Heart Rate According to the study, a stable signal was ...

International health care products major, Covidien plc (COV) has won the approval of the U.S. Food and Drug Administration (“FDA”) for its motion-tolerant Nellcor pulse oximetry devices. The system ...

January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...

BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...

“Clinicians can feel confident using the Nellcor Portable SpO 2 Patient Monitoring System for these important patient assesments,” said Dr. Scott Kelley, chief medical officer, Respiratory and ...

DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...

Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE)-- Covidien, a leading global provider of healthcare products and recognized ...

Across the healthcare landscape, more and more conversations are focusing on health inequity. Specific to pulse oximetry, recent research, media, and regulatory discussions have been raising awareness ...

Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...

DUBLIN, Feb. 9, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the results of an independent, prospective observational study comparing the efficacy ...